Trials / Recruiting
RecruitingNCT06883123
Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost
Efficacy and Tolerability of Simbrinza and Rocklatan vs. Cosopt
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Prairie Eye Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A randomized, multi-site, parallel-group, prospective study of patients who are adults with a diagnosis of mild to moderate open-angle glaucoma (OAG), currently on an on-label use of combination topical medication of Cosopt and Latanoprost for a minimum of 1 month.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Simbrinza 0.2%-1% Ophthalmic Suspension | brinzolamide and brimonidine tartrate |
| DRUG | Rocklatan 0.02%-0.005% Ophthalmic Solution | netarsudil and latanoprost |
| DRUG | Cosopt PF 2%-0.5% Ophthalmic Solution | dorzolamide hydrochloride and timolol maleate |
| DRUG | Latanoprost 0.005% Ophthalmic Solution | Latanoprost |
Timeline
- Start date
- 2025-05-14
- Primary completion
- 2026-04-01
- Completion
- 2026-04-01
- First posted
- 2025-03-19
- Last updated
- 2025-05-15
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06883123. Inclusion in this directory is not an endorsement.